Domestic and foreign guideline overview on prevention and treatment of thromboembolism in patients with coronavirus disease 2019.
Adverse Drug Reactions Journal
; 24(4):197-202, 2022.
Artículo
en Chino
| EMBASE | ID: covidwho-2302140
ABSTRACT
Coronavirus disease 2019 (COVID-19) can increase the risk of thrombosis and arterial embolism events in patients. The more serious the condition, the higher the risk. Therefore, many academic groups at home and abroad have successively issued guidelines on the prevention and treatment of thrombosis in patients with COVID-19. Among them, American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 (ASH guidelines) and its updates are newer and have more detailed recommendations on the application of anticoagulant drugs to prevent venous thromboembolism in acutely and critically ill patients with COVID-19. This review aims to provide reference for clinic through general viewing the ASH guidelines as well as other relevant guidelines at home and abroad.Copyright © 2022 Adverse Drug Reactions Journal.
Anticoagulants; covid-19; Preventive medicine; Thrombosis; anticoagulant therapy; article; coronavirus disease 2019; critically ill patient; human; medical society; practice guideline; priority journal; thrombosis prevention; venous thromboembolism/dt [Drug Therapy]; venous thromboembolism/pc [Prevention]; anticoagulant agent/dt [Drug Therapy]
Texto completo:
Disponible
Colección:
Bases de datos de organismos internacionales
Base de datos:
EMBASE
Idioma:
Chino
Revista:
Adverse Drug Reactions Journal
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS